The role of GATA-3 in T-cell lymphomas
GATA-3 在 T 细胞淋巴瘤中的作用
基本信息
- 批准号:8580615
- 负责人:
- 金额:$ 17.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-26 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:B-Cell NonHodgkins LymphomaBinding ProteinsBioinformaticsBiologic CharacteristicCell Differentiation processCell LineageCellsChIP-seqCharacteristicsClassificationClinicalDiagnosisDiseaseExclusionFoundationsGene ExpressionGene Expression ProfileGene TargetingGenetic TranscriptionGenomeGenomicsGoalsGrowthHealthImmunityIncidenceKnowledgeLinkLymphomaLymphoproliferative DisordersMalignant - descriptorMalignant NeoplasmsMolecularMyelogenousNon-Hodgkin&aposs LymphomaNormal CellPathogenesisPeripheralPhenotypePopulationProductionRegulationRegulatory T-LymphocyteResearchResearch PersonnelRoleSpecimenStromal CellsT cell differentiationT memory cellT-Cell DevelopmentT-Cell LymphomaT-LymphocyteTestingTh2 CellsTherapeuticTranscriptional RegulationTumor BiologyUnited StatesWorkcancer cellcareercytokineimprovedmacrophagemalignant lymphocytemouse modelneoplastic cellnoveloutcome forecastprogramsskillstranscription factortumortumor growthtumor microenvironment
项目摘要
DESCRIPTION (provided by applicant): The T-cell lymphomas, representing approximately 10% of all non-Hodgkin lymphomas, are heterogeneous, poorly understood, and generally associated with a dismal prognosis. The cell of origin for most T-cell lymphoproliferative disorders has remained elusive and represents a barrier to further advances in this field. Normal T cells, under the influence of specific transcription factors, differentiate into functionally disinct populations following antigenic stimulation. For example, GATA-binding protein 3 (GATA-3) is a transcription factor that controls T-cell differentiation into T helper type 2 (Th2) cells. We have
shown that myeloid-derived cells are regulated by cytokines transcriptionally regulated by GATA-3 and that these cells, including lymphoma-associated macrophages, promote the growth and survival of malignant T cells. Therefore, we hypothesized that a subset of T-cell lymphomas may be Th2-cell derived and regulate their microenvironment by producing cytokines that are transcriptionally regulated by GATA-3. In support of this hypothesis, we have found that a subset of T-cell lymphomas with an especially poor prognosis expresses GATA-3 and that its expression is associated with clinical and biologic characteristics resembling Th2 cells. Therefore, we aim to test the hypothesis that GATA-3 expression identifies a previously uncharacterized subset of T-cell lymphomas that exploit a GATA-3 driven transcriptional program to regulate lymphoma-associated macrophages within the tumor microenvironment. This hypothesis may support a novel paradigm in tumor biology with implications that extend beyond the T-cell lymphomas. Namely, transcriptional programs that determine cell lineage and differentiation in malignant cells may regulate stromal cells within the tumor microenvironment that are required for tumor growth.
描述(由申请人提供):T细胞淋巴瘤约占所有非霍奇金淋巴瘤的10%,是异质性的,了解不多,通常预后不良。大多数T细胞淋巴增生性疾病的起源细胞仍然难以捉摸,并代表了该领域进一步发展的障碍。正常T细胞在特异性转录因子的影响下,在抗原刺激后分化成功能不同的群体。例如,GATA结合蛋白3(加塔-3)是控制T细胞分化为T辅助2型(Th 2)细胞的转录因子。我们有
显示骨髓来源的细胞受由加塔-3转录调节的细胞因子调节,并且这些细胞,包括淋巴瘤相关巨噬细胞,促进恶性T细胞的生长和存活。因此,我们假设T细胞淋巴瘤的一个子集可能是Th 2细胞衍生的,并通过产生由加塔-3转录调节的细胞因子来调节其微环境。为了支持这一假设,我们发现一个预后特别差的T细胞淋巴瘤亚群表达加塔-3,并且其表达与类似于Th 2细胞的临床和生物学特征相关。因此,我们的目标是测试的假设,即加塔-3表达确定了以前未表征的子集的T细胞淋巴瘤,利用加塔-3驱动的转录程序,以调节淋巴瘤相关的巨噬细胞内的肿瘤微环境。这一假说可能支持一种新的模式,在肿瘤生物学的影响,延伸超出T细胞淋巴瘤。也就是说,决定恶性细胞中细胞谱系和分化的转录程序可以调节肿瘤生长所需的肿瘤微环境内的基质细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ryan A Wilcox其他文献
Speci fi c Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program
结节性淋巴细胞为主的霍奇金淋巴瘤中特定的 Polo 样激酶 1 表达表明完整的免疫监视计划
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Jonathan Weiss;Kathryn Gibbons;Vida Ehyaee;Vanessa Perez;Alejandro Zevallos;M. Maienschein;Eileen Brister;Maria Sverdlov;Eshana Shah;Jayalakshmi Balakrishna;Emily Symes;John K. Frederiksen;Peter H. Gann;Robert Post;Nicolas Lopez;John Reneau;G. Venkataraman;N. Bailey;Noah A. Brown kk;Mina L. Xu;Ryan A Wilcox;K. Inamdar;Carlos Murga - 通讯作者:
Carlos Murga
OTT_A_155778 8003..8014
OTT_A_155778 8003..8014
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
J. Girard;John Reneau;Sumana Devata;Ryan A Wilcox;M. Kamiński;Jessica Mercer;Shannon Carty;Tycel J Phillips - 通讯作者:
Tycel J Phillips
Myeloid-derived suppressor cells: therapeutic modulation in cancer.
骨髓源性抑制细胞:癌症的治疗调节。
- DOI:
10.2741/e423 - 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Ryan A Wilcox - 通讯作者:
Ryan A Wilcox
Progressive Apraxia of Speech: Might There Be Subtypes?
进行性言语失用:可能存在亚型吗?
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
Jonathan Weiss;Kathryn Gibbons;Vida Ehyaee;Vanessa Perez;Alejandro Zevallos;M. Maienschein;Eileen Brister;Maria Sverdlov;Eshana Shah;Jayalakshmi Balakrishna;Emily Symes;John K. Frederiksen;Peter H. Gann;Robert Post;Nicolas Lopez;John Reneau;G. Venkataraman;N. Bailey;Noah A. Brown kk;Mina L. Xu;Ryan A Wilcox;K. Inamdar;Carlos Murga - 通讯作者:
Carlos Murga
Ryan A Wilcox的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ryan A Wilcox', 18)}}的其他基金
Pacritinib in rel/refr T-cell lymphomas
帕克里替尼治疗 rel/refr T 细胞淋巴瘤
- 批准号:
10686109 - 财政年份:2021
- 资助金额:
$ 17.86万 - 项目类别:
Pacritinib in rel/refr T-cell lymphomas
帕克里替尼治疗 rel/refr T 细胞淋巴瘤
- 批准号:
10271682 - 财政年份:2021
- 资助金额:
$ 17.86万 - 项目类别:
Notch and GATA-3 as novel therapeutic targets in T-cell lymphomas
Notch 和 GATA-3 作为 T 细胞淋巴瘤的新治疗靶点
- 批准号:
10531562 - 财政年份:2019
- 资助金额:
$ 17.86万 - 项目类别:
Notch and GATA-3 as novel therapeutic targets in T-cell lymphomas
Notch 和 GATA-3 作为 T 细胞淋巴瘤的新治疗靶点
- 批准号:
10318634 - 财政年份:2019
- 资助金额:
$ 17.86万 - 项目类别:
THE T-CELL RECEPTOR'S ROLE IN T-CELL LYMPHOMA PATHOGENESIS
T 细胞受体在 T 细胞淋巴瘤发病机制中的作用
- 批准号:
10558576 - 财政年份:2019
- 资助金额:
$ 17.86万 - 项目类别:
THE T-CELL RECEPTOR'S ROLE IN T-CELL LYMPHOMA PATHOGENESIS
T 细胞受体在 T 细胞淋巴瘤发病机制中的作用
- 批准号:
10098010 - 财政年份:2019
- 资助金额:
$ 17.86万 - 项目类别:
THE T-CELL RECEPTOR'S ROLE IN T-CELL LYMPHOMA PATHOGENESIS
T 细胞受体在 T 细胞淋巴瘤发病机制中的作用
- 批准号:
10335179 - 财政年份:2019
- 资助金额:
$ 17.86万 - 项目类别:
Notch and GATA-3 as novel therapeutic targets in T-cell lymphomas
Notch 和 GATA-3 作为 T 细胞淋巴瘤的新治疗靶点
- 批准号:
10054184 - 财政年份:2019
- 资助金额:
$ 17.86万 - 项目类别:
相似海外基金
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 17.86万 - 项目类别:
Discovery Projects
Structural classification of NHEJ pathways; unravelling the role of Ku-binding proteins
NHEJ通路的结构分类;
- 批准号:
MR/X00029X/1 - 财政年份:2023
- 资助金额:
$ 17.86万 - 项目类别:
Research Grant
BRC-BIO: Evolutionary Patterns of Ice-Binding Proteins in North Pacific Intertidal Invertebrates
BRC-BIO:北太平洋潮间带无脊椎动物冰结合蛋白的进化模式
- 批准号:
2312378 - 财政年份:2023
- 资助金额:
$ 17.86万 - 项目类别:
Standard Grant
Exploring the roles and functions of sex steroid hormone receptor-associated RNA binding proteins in the development of geriatric diseases.
探索性类固醇激素受体相关 RNA 结合蛋白在老年疾病发展中的作用和功能。
- 批准号:
23K06408 - 财政年份:2023
- 资助金额:
$ 17.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
膜结合蛋白的紫外等离子增强手性光谱
- 批准号:
10680969 - 财政年份:2023
- 资助金额:
$ 17.86万 - 项目类别:
Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins
研究帕金森病蛋白 α-突触核蛋白和 RNA 结合蛋白之间的生理和病理生理联系
- 批准号:
10744556 - 财政年份:2023
- 资助金额:
$ 17.86万 - 项目类别:
Structural and computational analysis of immune-related RNA-binding proteins
免疫相关 RNA 结合蛋白的结构和计算分析
- 批准号:
23K06597 - 财政年份:2023
- 资助金额:
$ 17.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of carbohydrate-binding proteins and their applications
碳水化合物结合蛋白的表征及其应用
- 批准号:
23K05034 - 财政年份:2023
- 资助金额:
$ 17.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A machine learning approach to identify carbon dioxide-binding proteins for sustainability and health
一种机器学习方法来识别二氧化碳结合蛋白以实现可持续发展和健康
- 批准号:
2838427 - 财政年份:2023
- 资助金额:
$ 17.86万 - 项目类别:
Studentship
The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
- 批准号:
10827567 - 财政年份:2023
- 资助金额:
$ 17.86万 - 项目类别: